Heart Failure

AI-enabled remote cardiac monitoring offers continuous data on heart activity, allowing for the early detection of arrhythmias, optimized treatment timing, and improved sleep-related heart health management.

New insights into heart failure risks in Native American communities are highlighting the need to address social determinants of health.

Women's health extends beyond reproductive health, yet much of the research in women's health focuses on these "below the belt" health issues, despite data showing that women disproportionately suffer from certain health conditions, such as heart failure.

Investigators compare the impact of semaglutide for preserved ejection fraction and reduced ejection fraction, which both have different causes and responses to treatment.

Non-steroidal mineralocorticoid receptor antagonist, finerenone, demonstrated improved efficacy compared with existing steroidal treatment for patients.

Tirzepatide demonstrates statistically significant improvements in adult patients who have heart failure with preserved ejection fraction and obesity.

Investigators compared the criteria for eligibility in the VICTORIA trial with guideline and label criterion, finding a wider than expected population with heart failure were eligible for vericiguat therapy.

Consumer-wearable devices can monitor treatment response and provide continuous health data for patients with heart disease and atrial fibrillation.

The RECTIFIER framework was able to screen patients with heart failure more accurately and with a cheaper cost than traditional screening methods.

This narrative review dispels the long-held belief that reduction in salt intake leads to better health outcomes in patients with heart failure.

Semaglutide was found to have effects on glycemia, inflammation, and heart failure outcomes in sub analyses.

Small steps can accumulate and have a big impact on patients’ lives

The finding did not reach statistical significance in the primary composite endpoint.

Investigators reported a low incidence of adverse events after simultaneous vaccination against seasonal influenza and respiratory syncytial virus.

Although newly approved, there is some debate regarding the benefits and populations in which sotagliflozin will be the most effective.

Findings showed that pharmacists frequently communicated with patients to implement complex plans.

Initiating and optimizing heart failure guideline-directed medical therapy is critical to the comprehensive management of heart failure.

Cardioprotective antihyperglycemic agents are underutilized for inpatient care in heart failure patients. Lack of use can lead to preventable patient deaths and hospital readmissions.

The investigators identified 4 prognostic factors with high predictive ability and supported by moderate to high strength evidence beyond what is already available for cardiovascular disease.

Leg compression therapy was associated with decreased brain natriuretic peptide levels without any adverse events for patients with stable chronic heart failure.

Investigators determined the effectiveness of behavioral activation psychotherapy versus antidepressant medication management for inpatients with heart failure and depression.

A signaling pathway linking autophagy to nicotinamide adenine dinucleotide (NAD+), found indications that NAD+ depletion can lead to heart muscle cell dysfunction.

High intensity interval training (HIIT) showed improved heart failure outcomes compared to medium chain triacylglycerol, used for endurance performance among athletes, and the usual care.

Conclusions could not be made regarding whether lower risk was associated with improvement in heart failure or if the success of optimal medications led to better clinical outcomes.

In-hospital mortality and the Medicare Bundled Payments for Care Improvement (BPCI) model are not associated with changes in odds for Black individuals or female individuals.

From newsworthy moments to groundbreaking research, these were the most-read heart failure-related articles on Pharmacy Times in 2023.

In a study, most patients had specified SBP targets of less than 160 mmHg and all patients attained goal within a relatively short period of time.

The results of the study show the importance of considering neighborhood-level disparities to address and improve medication adherence, according to investigators.

Individuals received 4 daily short messages that reminding them to participate in self-care, active engagement, and early intervention for the first 30 days of the study.

Investigators also found that the results demonstrated lower death and hospitalization rates for those with advanced heart failure treated with cell therapy.